About Dr. Brent Boyett DMD, DO, DFASAM
Dr. Brent completed his undergraduate education at Birmingham-Southern College then completed his first secondary degree from the University of Alabama at Birmingham in 1994 with a D.M.D. degree.
​
Working during the summers and on weekends in dentistry he went on to medical school at the University of Health Sciences College of Osteopathic Medicine and graduated in 1998. He then began a three-year Family Medicine Residency with the University of Mississippi in Tupelo, which he completed in 2001. His emphasis during this training was internal medicine, anesthesia and oral surgery.
​
He was raised in Lamar County, Alabama and began his dental practice in Marion County in 1994. He established his medical practice in Hamilton, Alabama in 2001. He was dedicated to serving the residents of Marion County, as well as all surrounding counties with medical and dental services until 2019, at which time he left private practice and focused his medical career on treating and researching addiction disorders.
​
Dr. Boyett is now employed by North Mississippi Hospital System at the Neuroscience Institute, treating pain and addiction.
​
He is a Distinguished Diplomat of the American Society of Addiction Medicine, a Diplomat of the American Academy of Family Practice and the American Dental Society of Anesthesiology. Dr. Boyett first addiction board certification was through the American Board of Addiction Medicine (ABAM), in 2009. Dr. Boyett went on to pursue studies in addiction and in 2018 became Board Certified in Addiction Medicine through The American Board of Preventive Medicine. In the pursuit of additional knowledge, Dr. Boyett completed studies with the Integrative Psychiatry Institute, to become certified as a Ketamine Medical Provider.
​
Given his extensive training in the field of addiction disorders, Dr. Boyett currently travels the nation with the goal of increasing knowledge on the use of opioids, cannabis and psychedelics on how they affect the brain. Research on psychedelics continue and what the future of psychedelics looks like (especially ketamine), and the medical us of cannabis, is ongoing.